Immune cell duo takes on tough tumors in early trial
NCT ID NCT07475182
First seen Mar 28, 2026 · Last updated May 23, 2026 · Updated 9 times
Summary
This study tests a new treatment that combines two types of immune cells—dendritic cells and CAR-T cells—to fight advanced solid cancers like stomach, colon, and pancreatic cancer. The goal is to see if this combination is safe and can shrink tumors. About 10 adults will take part in this early-stage trial.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID CANCERS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hainan Cancer Hospital
RECRUITINGHaikou, Hainan, 570311, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.